Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mendes

Showing results (251-260 of 473) with videos related to

Pageof 48
Sort By:
Pharmacy Practice|March 25, 2016
Medication reconciliation at patient admission: a randomized controlled trialAntonio E Mendes, Natália F Lombardi, Vânia S Andrzejevski, et al.
Antimicrobial Agents and Chemotherapy|March 20, 2013
Potency and spectrum of activity of AN3365, a novel boron-containing protein synthesis inhibitor, tested against clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilliRodrigo E Mendes, M R K Alley, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2017
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae IsolatesHelio S Sader, Rodrigo E Mendes, Michael A Pfaller, et al.
Open Forum Infectious Diseases|March 22, 2019
Antimicrobial Susceptibility of <i>Streptococcus pneumoniae</i> from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997-2016)Helio S Sader, Rodrigo E Mendes, Jennifer Le, et al.
Open Forum Infectious Diseases|March 22, 2019
Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among <i>Enterobacteriaceae</i> Isolates in 20 Years of the SENTRY Antimicrobial Surveillance ProgramMariana Castanheira, Lalitagauri M Deshpande, Rodrigo E Mendes, et al.
Microbiology Spectrum|January 10, 2023
Contemporary Evaluation of Tebipenem <i>In Vitro</i> Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019-2020)Rodrigo E Mendes, S J Ryan Arends, Jennifer M Streit, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2010
Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007Mariana Castanheira, Lalitagauri M Deshpande, Dilip Mathai, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2010
Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, ItalyRodrigo E Mendes, Lalitagauri M Deshpande, David J Farrell, et al.
Andrologia|March 1, 1991
Low energy narrow band non-coherent infrared illumination of human semen and isolated spermR Singer, M Sagiv, M Barnet, et al.
Antimicrobial Agents and Chemotherapy|April 9, 2008
First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United StatesRodrigo E Mendes, Lalitagauri M Deshpande, Mariana Castanheira, et al.
Pageof 48

Showing results (251-260 of 473) with videos related to

Sort By:
Pageof 48
Pharmacy Practice|March 25, 2016
Medication reconciliation at patient admission: a randomized controlled trialAntonio E Mendes, Natália F Lombardi, Vânia S Andrzejevski, et al.
Antimicrobial Agents and Chemotherapy|March 20, 2013
Potency and spectrum of activity of AN3365, a novel boron-containing protein synthesis inhibitor, tested against clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilliRodrigo E Mendes, M R K Alley, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2017
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae IsolatesHelio S Sader, Rodrigo E Mendes, Michael A Pfaller, et al.
Open Forum Infectious Diseases|March 22, 2019
Antimicrobial Susceptibility of <i>Streptococcus pneumoniae</i> from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997-2016)Helio S Sader, Rodrigo E Mendes, Jennifer Le, et al.
Open Forum Infectious Diseases|March 22, 2019
Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among <i>Enterobacteriaceae</i> Isolates in 20 Years of the SENTRY Antimicrobial Surveillance ProgramMariana Castanheira, Lalitagauri M Deshpande, Rodrigo E Mendes, et al.
Microbiology Spectrum|January 10, 2023
Contemporary Evaluation of Tebipenem <i>In Vitro</i> Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019-2020)Rodrigo E Mendes, S J Ryan Arends, Jennifer M Streit, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2010
Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007Mariana Castanheira, Lalitagauri M Deshpande, Dilip Mathai, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2010
Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, ItalyRodrigo E Mendes, Lalitagauri M Deshpande, David J Farrell, et al.
Andrologia|March 1, 1991
Low energy narrow band non-coherent infrared illumination of human semen and isolated spermR Singer, M Sagiv, M Barnet, et al.
Antimicrobial Agents and Chemotherapy|April 9, 2008
First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United StatesRodrigo E Mendes, Lalitagauri M Deshpande, Mariana Castanheira, et al.
Pageof 48